Aligos Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aligos Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.68M	$ 1.08M	$ 4.29M	$ 140.00K	-
Gross Profit	$ 672.00K	$ 1.08M	$ 4.29M	$ 140.00K	-
EBIT	$ -32.22M	$ -18.01M	$ -18.03M	$ -22.92M	$ -21.91M
EBITDA	$ -31.48M	$ -17.34M	$ -17.43M	$ -22.29M	$ -21.10M
Net Income Common Stockholders	$ -27.89M	$ -18.04M	$ -18.79M	$ -22.95M	$ -21.94M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 135.70M	$ 70.43M	$ 90.88M	$ 103.91M	$ 125.93M
Total Assets	$ 151.53M	$ 85.85M	$ 106.13M	$ 121.74M	$ 141.86M
Total Debt	$ 11.14M	$ 11.77M	$ 12.41M	$ 11.96M	$ 12.57M
Net Debt	$ -124.57M	$ -58.66M	$ -78.47M	$ -91.95M	$ -113.35M
Total Liabilities	$ 59.45M	$ 31.03M	$ 36.49M	$ 36.99M	$ 146.71M
Stockholders Equity	$ 92.08M	$ 54.82M	$ 69.59M	$ 84.75M	$ 103.92M
Cash Flow	-
Free Cash Flow	$ -22.68M	$ -20.38M	$ -13.61M	$ -22.35M	$ -16.89M
Operating Cash Flow	$ -22.66M	$ -20.38M	$ -13.62M	$ -22.34M	$ -16.80M
Investing Cash Flow	$ -7.00K	$ -9.00K	$ 25.00M	$ 19.99M	$ 11.60M
Financing Cash Flow	$ 87.94M	$ -21.00K	$ 414.00K	$ -1.00K	$ 101.00K

Currency in USD

Aligos Therapeutics Earnings and Revenue History

Income Statement >

Aligos Therapeutics Debt to Assets

Balance Sheet >

Aligos Therapeutics Cash Flow

Cash Flow >

Aligos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing